Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Parasitology international

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1383-5769(02)00044-2PMID 12421636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.

  2000cited by this paper
• Trypanosomiasis and leishmaniasis : biology and control

  1998cited by this paper
• Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee.

  1998cited by this paper
• Drug resistance in trypanosomatids.

  1997cited by this paper
• Chemotherapy of human leishmaniasis and trypanosomiasis.

  1997cited by this paper
• Topical chemotherapy for experimental African trypanosomiasis with cerebral involvement: the use of melarsoprol combined with the 5‐nitroimidazole, megazol

  1996cited by this paper
• Topical chemotherapy for experimental murine African CNS‐trypanosomiasis: the successful use of the arsenical, melarsoprol, combined with the 5‐nitroimidazoles, fexinidazole or MK‐436

  1996cited by this paper
• Suramin treatment of experimental Trypanosoma brucei infection of the central nervous system.

  1995cited by this paper
• Successful treatment of experimental murine Trypanosoma brucei infection with topical melarsoprol gel.

  1995cited by this paper
• The treatment of human African trypanosomiasis.

  1994cited by this paper
• Combination chemotherapy of CNS trypanosomiasis.

  1993cited by this paper
• Topical melarsoprol for trypanosomiasis.

  1993cited by this paper
• Immunopathology in central nervous system human African trypanosomiasis.

  1992cited by this paper
• African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis.

  1991cited by this paper
• Trypanosomiasis and encephalitis: possible aetiology and treatment.

  1989cited by this paper
• Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.

  1983cited by this paper
• Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.

  1983cited by this paper
• Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis.

  1981cited by this paper
• Immunopathological and chemotherapeutic studies in experimental trypanosomiasis with special reference to the heart and brain.

  1980cited by this paper
• Trypanosomiasis and leishmaniasis.

  1971cited by this paper
• The African trypanosomiases

  1970cited by this paper
• The lesions produced in the central nervous system by certain organic arsenical compounds.

  1959cited by this paper
• Mel B in the treatment of tryparsamide resistant T. gambiense sleeping sickness: observations on drug resistance in the trypanosomes of the French Cameroun.

  1951cited by this paper
• Mel B in the treatment of human trypanosomiasis.

  1949cited by this paper
• Subsequent histories of six cases of Trypanosoma rhodesiense infection treated with “Bayer 205” or “Fourneau 309”

  1934cited by this paper

• Anti-trypanosomatid drug discovery: progress and challenges

  2022cites this paper
• In Vivo Bioluminescence Imaging to Assess Compound Efficacy Against Trypanosoma brucei.

  2020cites this paper
• Enzymatic Targets in Trypanosoma brucei.

  2016cites this paper
• Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis.

  2016cites this paper
• A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasis.

  2015cites this paper
• Development of an imaging model of a CNS infection with African trypanosomes

  2015cites this paper
• Optimizing bioluminescence imaging to study protozoan parasite infections.

  2014cites this paper
• Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase

  2013cites this paper
• In Vivo Imaging of Trypanosome-Brain Interactions and Development of a Rapid Screening Test for Drugs against CNS Stage Trypanosomiasis

  2013influential citation
• Suramin ameliorates collagen induced arthritis.

  2012cites this paper
• Evaluation of potential therapeutic agents for antiinflammatory activity

  2012cites this paper
• The Distribution of Nifurtimox Across the Healthy and Trypanosome-Infected Murine Blood-Brain and Blood-Cerebrospinal Fluid Barriers

  2011cites this paper
• Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis

  2010cites this paper
• Trypanosomatid parasites causing neglected diseases.

  2010cites this paper
• Epidemiology, control and potential insect vectors of Trypanosoma evansi (surra) in village livestock in southern Philippines

  2010cites this paper
• Human African trypanosomiasis

  2010cites this paper
• Immunobiology of African Trypanosomes: Need of Alternative Interventions

  2010cites this paper
• Human African trypanosomiasis, chemotherapy and CNS disease.

  2009cites this paper
• New bicyclic amines: synthesis and SARs of their action against the causative organisms of malaria and sleeping sickness.

  2009cites this paper
• Synthesis of bicyclic amines and their activities against Trypanosoma brucei rhodesiense and Plasmodium falciparum K1

  2008cites this paper
• The continuing problem of human African trypanosomiasis (sleeping sickness)

  2008cites this paper
• Avaliação da participação das ecto-nucleotidases do Trypanosoma cruzi nos processos de infecção e virulência em modelo murino

  2008cites this paper
• Novel azabicyclo[3.2.2]nonane derivatives and their activities against Plasmodium falciparum K1 and Trypanosoma brucei rhodesiense.

  2008cites this paper
• in hypobaric hypoxia-induced hypothermia Cosignaling of adenosine and adenosine triphosphate

  2006cites this paper
• Cosignaling of adenosine and adenosine triphosphate in hypobaric hypoxia-induced hypothermia.

  2006cites this paper
• Structural Requirements for the Antiprotozoal Activity of 4-Aminobicyclo[2.2.2]octan-2-ols

  2006cites this paper
• Antiprotozoal activities of new bicyclo[2.2.2]octan-2-imines and esters of bicyclo[2.2.2]octan-2-ols.

  2005cites this paper
• Characterization of [3H]-forskolin binding sites in young and adult rat brain cortex: identification of suramin as a competitive inhibitor of [3H]-forskolin binding.

  2005cites this paper
• Synthesis and evaluation of the antitrypanosomal and antiplasmodial activities of new 4-aminobicyclo[2.2.2]octane derivatives.

  2005cites this paper
• Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin.

  2005cites this paper
• The problem of human African trypanosomiasis

  2005cites this paper
• Characterization of ( 3 H)-forskolin binding sites in young and adult rat brain cortex: identification of suramin as a competitive inhibitor of ( 3 H)-forskolin binding

  2005cites this paper
• Synthesis of 2-azabicyclo[3.2.2]nonanes from bicyclo[2.2.2]octan-2-ones and their activities against Trypanosoma brucei rhodesiense and Plasmodium falciparum K1.

  2005cites this paper
• Megazol combined with suramin improves a new diagnosis index of the early meningo‐encephalitic phase of experimental African trypanosomiasis

  2004cites this paper
• DNA topoisomerases in life and death: implications in kinetoplastid protozoa.

  2004cites this paper
• The trypanosomiases.

  2003cites this paper